Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine

ENHANCE Study Investigators

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)61-79
Number of pages19
JournalCns Drugs
Volume33
Issue number1
DOIs
Publication statusPublished - Jan 2019

Keywords

  • IMPACT-SCALE MSIS-29
  • BERG BALANCE SCALE
  • ABILHAND QUESTIONNAIRE
  • MANUAL ABILITY
  • DALFAMPRIDINE
  • RELIABILITY
  • EFFICACY
  • PEOPLE
  • GAIT
  • RESPONSIVENESS

Cite this